Second dose of measles-mumps-rubella-varicella vaccine (MMRV) and the risk of febrile convulsions

CONCLUSION: Use of MMRV at second dose is not associated with an increased risk of FC compared to MMR + V or MMR, irrespective of age, sex, history of FC, or type of first dose vaccine.PMID:35232594 | DOI:10.1016/j.vaccine.2022.02.072

Source: Vaccine - March 2, 2022 Category: Allergy & Immunology Authors: Wiebke Sch äfer Tammo Reinders Tania Schink Source Type: research